Benralizumab: an updated treatment of eosinophilic asthma.

Expert Review of Respiratory Medicine
Breda Cushen, Andrew Menzies-Gow

Abstract

Introduction: An estimated 5-10% of people with asthma have disease which remains uncontrolled despite maximal treatment with inhaled corticosteroids and long-acting beta-agonists. Benralizumab is currently licensed for use in patients with severe asthma who have an eosinophilic phenotype. Benralizumab depletes eosinophils by binding to the anti-IL5 receptor on the surface of eosinophils, mitigating the effect of IL-5 on eosinophil proliferation and survival, and induces natural killer cell-mediated eosinophil apoptosis.Areas covered: The authors review the mechanism of action and pharmacokinetic profile of Benralizumab and summarize the scientific data supporting its clinical efficacy and safety in severe asthma. Further, the authors highlight future studies of Benralizumab in asthma and other diseases.Expert opinion: Benralizumab lowers exacerbation rates, symptom burden, and oral glucocorticoid use, and improves lung function, in patients with severe eosinophilic asthma. Benralizumab is well tolerated and is an attractive choice for patients and physicians due to its eosinophil-depleting mechanism of action and less frequent dosing schedule. More data is needed to guide the selection of biologic therapy in severe asthma pati...Continue Reading

References

Oct 11, 1990·The New England Journal of Medicine·J BousquetP Godard
Jan 5, 2002·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·A Menzies-Gow, D S Robinson
Oct 31, 2002·American Journal of Respiratory and Critical Care Medicine·Patrick T Flood-PageDouglas S Robinson
Jan 10, 2004·The Journal of Allergy and Clinical Immunology·Amy D Klion, Thomas B Nutman
Feb 24, 2009·Advances in Immunology·Carine Blanchard, Marc E Rothenberg
Mar 7, 2009·The New England Journal of Medicine·Pranabashis HaldarIan D Pavord
Jun 2, 2010·The Journal of Allergy and Clinical Immunology·Roland KolbeckAnthony J Coyle
Feb 2, 2011·The Journal of Allergy and Clinical Immunology·Jan LötvallPaul A Greenberger
Jul 12, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anna E PrizmentAaron R Folsom
Aug 20, 2011·American Journal of Respiratory and Critical Care Medicine·Mario CastroUNKNOWN Res-5-0010 Study Group
Nov 17, 2012·Nature Reviews. Immunology·Helene F RosenbergPaul S Foster
Jul 23, 2013·The Journal of Allergy and Clinical Immunology·Michel LavioletteNestor A Molfino
Aug 8, 2013·Nature Medicine·Guy G BrusselleKen R Bracke
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague
Feb 21, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M W Johansson
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
Oct 7, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Robert S ZeigerAniket A Kawatkar
Jun 6, 2016·Trends in Parasitology·Lu Huang, Judith A Appleton
Jan 22, 2017·CPT: Pharmacometrics & Systems Pharmacology·B WangL K Roskos
May 23, 2017·The New England Journal of Medicine·Parameswaran NairUNKNOWN ZONDA Trial Investigators
May 27, 2017·The Lancet. Respiratory Medicine·Gary T FergusonUNKNOWN BISE Study Investigators
Jul 18, 2017·Frontiers in Medicine·Claire N McBrien, Andrew Menzies-Gow
Jul 26, 2017·Trends in Cancer·Hadar ReichmanAriel Munitz
Jan 9, 2018·Oncoimmunology·Gilda VarricchiGiovanna Schiavoni
Feb 8, 2018·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Bradley E ChippsMitchell Goldman
Apr 3, 2018·Drug Design, Development and Therapy·Corrado PelaiaGirolamo Pelaia
May 22, 2018·The New England Journal of Medicine·Klaus F RabeAriel Teper
Aug 25, 2018·The European Respiratory Journal·Eugene R BleeckerJames G Zangrilli
Sep 12, 2018·The Journal of Allergy and Clinical Immunology·William BusseNecdet B Gunsoy
Mar 13, 2019·Journal of Medical Biography·D J Canale
Apr 27, 2019·Drugs in Context·Francesco MenzellaNicola Facciolongo
May 22, 2019·The New England Journal of Medicine·Gerard J CrinerUNKNOWN TERRANOVA Study Investigators

❮ Previous
Next ❯

Citations

Nov 14, 2020·Mucosal Immunology·Patricia P Ogger, Adam J Byrne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.